Ketorolac Tromethamine description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Ketorolac Tromethamine

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

Ketorolac tromethamine tablets, a non-steroidal anti-inflammatory drug (NSAID), are indicated for the short-term (up to 5 days in adults), management of moderately severe acute pain that requires analgesia at the opioid level and only as continuation treatment following IV or IM dosing of ketorolac tromethamine, if necessary. The total combined duration of use of ketorolac tromethamine tablets and ketorolac tromethamine should not exceed 5 days.
Ketorolac tromethamine tablets are not indicated for use in pediatric patients and they are NOT indicated for minor or chronic painful conditions. Increasing the dose of ketorolac tromethamine tablets beyond a daily maximum of 40 mg in adults will not provide better efficacy but will increase the risk of developing serious adverse events.

GASTROINTESTINAL RISK
  • ●     Ketorolac tromethamine, including ketorolac tromethamine tablets can cause peptic ulcers, gastrointestinal bleeding and/or perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Therefore, ketorolac tromethamine is CONTRAINDICATED in patients with active peptic ulcer disease, in patients with recent gastrointestinal bleeding or perforation, and in patients with a history of peptic ulcer disease or gastrointestinal bleeding. Elderly patients are at greater risk for serious gastrointestinal events (see WARNINGS).
CARDIOVASCULAR RISK
  • ●     NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk (see WARNINGS and CLINICAL STUDIES).
  • ●     Ketorolac tromethamine is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery (see WARNINGS).
RENAL RISK
  • ●     Ketorolac tromethamine is CONTRAINDICATED in patients with advanced renal impairment and in patients at risk for renal failure due to volume depletion (see WARNINGS).
RISK OF BLEEDING
  • ●     Ketorolac tromethamine inhibits platelet function and is, therefore, CONTRAINDICATED in patients with suspected or confirmed cerebrovascular bleeding, patients with hemorrhagic diathesis, incomplete hemostasis and those at high risk of bleeding (see WARNINGS and PRECAUTIONS).
Ketorolac tromethamine is CONTRAINDICATED as prophylactic analgesic before any major surgery.
RISK DURING LABOR AND DELIVERY

  • ●     The use of ketorolac tromethamine in labor and delivery is contraindicated because it may adversely affect fetal circulation and inhibit uterine contractions. The use of ketorolac tromethamine is contraindicated in nursing mothers because of the potential adverse effects of prostaglandin-inhibiting drugs on neonates.
CONCOMITANT USE WITH NSAIDs
  • ●     Ketorolac tromethamine is CONTRAINDICATED in patients currently receiving aspirin or NSAIDs because of the cumulative risk of inducing serious NSAID-related side effects.
SPECIAL POPULATIONS
  • ●     Dosage should be adjusted for patients 65 years or older, for patients under 50 kg (110 lbs) of body weight (see DOSAGE AND ADMINISTRATION) and for patients with moderately elevated serum creatinine (see WARNINGS).

KETOROLAC TROMETHAMINE DESCRIPTION


Ketorolac Tromethamine





CLINICAL PHARMACOLOGY

Pharmacodynamics



Pharmacokinetics


Comparison of IV, IM, and Oral Pharmacokinetics


Linear Kinetics


Absorption


Distribution



Metabolism


Excretion



Accumulation



Kinetics in Special Populations

Geriatric Patients


Pediatric Patients


Renal Insufficiency




Hepatic Insufficiency


Race



*#*#
*
*
IV Administration


CLINICAL STUDIES

Adult Patients


Pediatric Patients


INDICATIONS & USAGE



Acute Pain in Adult Patients



KETOROLAC TROMETHAMINE CONTRAINDICATIONS















WARNINGS





Gastrointestinal EffectsRisk of Ulceration, Bleeding, and Perforation





Hemorrhage



Renal Effects



Impaired Renal Function


Anaphylactoid Reactions


Cardiovascular Effects

Cardiovascular Thrombotic Events



Hypertension


Congestive Heart Failure and Edema


Skin Reactions


Pregnancy


PRECAUTIONS

General



Hepatic Effect



Hematologic Effect


Preexisting Asthma


INFORMATION FOR PATIENTS















LABORATORY TESTS



DRUG INTERACTIONS



Warfarin, Digoxin, Salicylate, and Heparin




Aspirin


Diuretics


Probenecid


Lithium


Methotrexate


ACE Inhibitors/Angiotensin II Receptor Antagonists



Antiepileptic Drugs


Psychoactive Drugs


Pentoxifylline


Nondepolarizing Muscle Relaxants


Selective Serotonin Reuptake Inhibitors (SSRIs)


CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY





PREGNANCY

Teratogenic Effects

Pregnancy category C


Nonteratogenic Effects



LABOR & DELIVERY



Effects on Fertility


NURSING MOTHERS



PEDIATRIC USE



GERIATRIC USE

(65 Years of Age)


KETOROLAC TROMETHAMINE ADVERSE REACTIONS





Body as a Whole:
Cardiovascular
Dermatologic:
Gastrointestinal:
Hemic and Lymphatic:
Metabolic and Nutritional:
Nervous System:
Reproductive, female:
Respiratory:
Special Senses:
Urogenital:

Body as a Whole:
Cardiovascular:
Dermatologic:
Gastrointestinal:
Hemic and Lymphatic:
Metabolic and Nutritional:
Nervous System:
Respiratory:
Special Senses
Urogenital:

Postmarketing Surveillance Study







OVERDOSAGE

Symptoms and Signs


Treatment



DOSAGE & ADMINISTRATION

Carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac tromethamine. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. In adults, the combined duration of use of IV or IM dosing of ketorolac tromethamine and ketorolac tromethamine tablets is not to exceed 5 days. In adults, the use of ketorolac tromethamine tablets is only indicated as continuation therapy to IV or IM dosing of ketorolac tromethamine.
Transition from IV or IM dosing of ketorolac tromethamine (single- or multiple-dose) to multiple-dose ketorolac tromethamine tablets:



Note:










HOW SUPPLIED





SPL MEDGUIDE

Medication Guide for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Rx only


What is the most important information I should know about medicines called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)?
NSAID medicines may increase the chance of a heart attack or stroke that can lead to death.

  • ●     with longer use of NSAID medicines
  • ●     in people who have heart disease
NSAID medicines should never be used right before or after a heart surgery called a "coronary artery bypass graft (CABG)."
NSAID medicines can cause ulcers and bleeding in the stomach and intestines at any time during treatment. Ulcers and bleeding:

  • ●     can happen without warning symptoms
  • ●     may cause death
The chance of a person getting an ulcer or bleeding increases with:
  • ●     taking medicines calledcorticosteroidsandanticoagulants
  • ●     longer use
  • ●     smoking
  • ●     drinking alcohol
  • ●     older age
  • ●     having poor health
NSAID medicines should only be used:
  • ●     exactly as prescribed
  • ●     at the lowest dose possible for your treatment
  • ●     for the shortest time needed
What are Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)?

  • ●     different types of arthritis
  • ●     menstrual cramps and other types of short-term pain
Who should not take a Non-Steroidal Anti-Inflammatory Drug (NSAID)?
Do not take an NSAID medicine:

  • ●     if you had an asthma attack, hives, or other allergic reaction with aspirin or any other NSAID medicine
  • ●     for pain right before or after heart bypass surgery
Tell your healthcare provider:
  • ●     about all of your medical conditions.
  • ●     about all of the medicines you take. NSAIDs and some other medicines can interact with each other and cause serious side effects. Keep a list of your medicines to show to your healthcare provider and pharmacist.
  • ●     if you are pregnant. NSAID medicines should not be used by pregnant women late in their pregnancy.
  • ●     if you are breastfeeding. Talk to your doctor.
What are the possible side effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)?

Get emergency help right away if you have any of the following symptoms:
  • ●     shortness of breath or trouble breathing
  • ●     chest pain
  • ●     weakness in one part or side of your body
  • ●     slurred speech
  • ●     swelling of the face or throat
Stop your NSAID medicine and call your healthcare provider right away if you have any of the following symptoms:
  • ●     nausea
  • ●     more tired or weaker than usual
  • ●     itching
  • ●     your skin or eyes look yellow
  • ●     stomach pain
  • ●     flu-like symptoms
  • ●     vomit blood
  • ●     there is blood in your bowel movement or it is black and sticky like tar
  • ●     unusual weight gain
  • ●     skin rash or blisters with fever
  • ●     swelling of the arms and legs, hands and feet

Other information about Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • ●     Aspirin is an NSAID medicine but it does not increase the chance of a heart attack. Aspirin can cause bleeding in the brain, stomach, and intestines. Aspirin can also cause ulcers in the stomach and intestines.
  • ●     Some of these NSAID medicines are sold in lower doses without a prescription (over-the-counter). Talk to your healthcare provider before using over-the-counter NSAIDs for more than 10 days.


**Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Ketorolac Tromethamine

Ketorolac Tromethamine

Ketorolac Tromethamine

Ketorolac Tromethamine TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-737(NDC:0093-0314)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
KETOROLAC TROMETHAMINE KETOROLAC 10 mg

Inactive Ingredients

Ingredient Name Strength
hydroxypropyl cellulose
HYPROMELLOSES
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline
polyethylene glycol
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
white 8 mm 93;314 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-737-40 25 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA074754 2011-12-28


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.